Aurigene Pharmaceutical Services

Hyderabad, India
Find alternatives to Aurigene Pharmaceutical Services for Oligonucleotide →
Program data pending ClinicalTrials.gov matching · Last scored 2026-10-29
63.0
Signal Score
○ FDA Inspections ○ Clinical Trials ○ SEC Filings ○ Press ○ EMA GMP ○ MHRA GMP

Quick Facts: Aurigene Pharmaceutical Services

Signal Score
63.0/100 (as of 2026-10-29)
Quality Compliance
Assessment pending
Headquarters
Hyderabad, India
Modalities
Oligonucleotide, Biologics
Active Programs
No ClinicalTrials.gov matches confirmed
Data Sources
FDA Data Dashboard, ClinicalTrials.gov, SEC EDGAR, press monitoring
Scored By
CDMO Signal — independent CDMO intelligence platform

About Aurigene Pharmaceutical Services

Pure-play CDMO.

Signal Score & Pillar Breakdown

Quality Compliance —
No FDA inspection records found. This CDMO may operate under a different legal name or may not have US FDA-inspected facilities.
FDA InspectionsNo US records on file
No FDA inspection records found for this manufacturer
Quality score requires FDA inspection data
Operations —
No ClinicalTrials.gov facility matches confirmed for this manufacturer.
Programs — no verified data
Sponsors— no verified data
ModalitiesOligonucleotide, Biologics
No clinical trial matches found for this manufacturer
Operational score requires ClinicalTrials.gov data
Scored from ClinicalTrials.gov and FDA records; SEC EDGAR and press items are shown as company signals, not scored. No unverified estimates shown.
Financial Stability 68.0
Parent company: Dr. Reddy's Laboratories
Financial assessment: 68.0/100
Source: company profile (public/private status, parent company)
Profile-based financial assessment
SEC FilingsPrivate company
Parent company: Dr. Reddy's Laboratories
Financial assessment: 68.0/100
Capacity 58.0
1 manufacturing site: Hyderabad, IN
Modalities: Oligonucleotide, Biologics
Capacity assessment: 58.0/100
Sites: Hyderabad, IN
Source: company profiles (manufacturing sites, modality breadth)
1 manufacturing site
1 manufacturing site: Hyderabad, IN
Modalities: Oligonucleotide, Biologics
Capacity assessment: 58.0/100

Hiring Activity Beta

Built from public job postings when a company's own roles can be read. Job postings are signals, not statements by the company; each one below links to the original. How we collect this
No hiring data yet. We haven't found a public jobs feed for this company.
Source: public careers pages · Checked Nov 20, 2026

Frequently Asked Questions About Aurigene Pharmaceutical Services

What is Aurigene Pharmaceutical Services's CDMO Signal Score?
Aurigene Pharmaceutical Services has a Signal Score of 63/100, based on quality, operations, financial stability, and capacity data.
Evaluating Aurigene Pharmaceutical Services for a manufacturing program?
Use the free AI matchmaker to compare Aurigene Pharmaceutical Services against other CDMOs by FDA, EMA, and clinical-trial data — no login required.
Find & compare CDMOs →
Represent this organization? Contact us to verify or update this profile.
See all CDMOs in:
Oligonucleotide CDMOs → Biologics CDMOs →

Similar CDMOs

Ajinomoto Bio-Pharma Services
San Diego, CA · Osaka, JP
Signal Score: 83.5
Oligonucleotide, Biologics, AAV
Corden Pharma
Plankstadt, DE · Caponago, IT · Boulder, CO
Signal Score: 83.1
mRNA, Oligonucleotide, Biologics
Curia (RNA/Advanced)
Albany, NY · Albuquerque, NM
Signal Score: 79.5
mRNA, Oligonucleotide, Biologics
Syngene International
Bengaluru, India
Signal Score: 80.3
Biologics, Cell Therapy
Anthem Biosciences
India
Small Molecule API, Peptides & Oligos, Biologics

Compare Aurigene Pharmaceutical Services with another CDMO

Side-by-side scoring, FDA inspection history, EMA/MHRA GMP coverage, and clinical-program footprint.
Compare side-by-side
See two CDMOs' scoring, inspection history, and clinical footprint next to each other.
Open comparison →
Run a sourcing search
Describe your program's requirements — Signal matches CDMOs against FDA, EMA/MHRA, ClinicalTrials.gov and capacity signals.
Search for a CDMO →
Get updates on Aurigene Pharmaceutical Services
Get an email when a CDMO on this list has a new FDA inspection, GMP certificate, or scoring change.